Through mass spectrometry-based phosphoproteomic data analysis, this study reveals a phosphoregulatory network that positions KMT2D as a dynamically phosphorylated epigenetic effector modulated by MEK–ERK signaling, with broad implications in cancer and developmental disorders. The gene discussed is KMT2D; the disease is cancer.